Applied Genetic Technologies Corp.
(NASDAQ : AGTC)

( )
AGTC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.23%89.071.3%$885.86m
AMGNAmgen Inc.
0.09%191.491.2%$554.58m
GILDGilead Sciences, Inc.
0.72%65.490.9%$453.28m
ONCESpark Therapeutics, Inc.
-0.25%113.6711.2%$443.24m
BIIBBiogen Inc.
-0.58%323.761.3%$352.26m
REGNRegeneron Pharmaceuticals, Inc.
-0.15%406.992.6%$278.79m
ILMNIllumina, Inc.
1.61%310.703.5%$273.06m
BPTHBio-Path Holdings, Inc.
-9.32%25.20190.1%$257.65m
VRTXVertex Pharmaceuticals Incorporated
-3.05%181.761.9%$239.61m
SRPTSarepta Therapeutics, Inc.
-0.28%126.4715.4%$205.98m
EXASExact Sciences Corporation
-0.85%91.1525.3%$189.71m
ALXNAlexion Pharmaceuticals, Inc.
-0.43%132.942.0%$178.02m
AAgilent Technologies, Inc.
0.28%81.201.6%$151.29m
IONSIonis Pharmaceuticals, Inc.
0.11%79.618.3%$101.25m
BMRNBioMarin Pharmaceutical Inc.
-2.06%91.444.3%$95.59m

Company Profile

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.